anonymous
Guest
anonymous
Guest
Who loves their new territory? Who believes 15 more reps will counteract a Keytruda indication successfully? Ha Ha. My territory got hacked.
This organization needs to exit oncology. This is another $%^& show like their previous attempt to enter the oncology arena. They are clueless and have no idea what they are doing. People have left and will continue to do so.
And Praul-u-crap. Never made money, never will. Can’t give that crap away. Snake oil.From the makers of ZalCRAP
People are still interviewing like crazy and will as soon as they get back from the holidays. Let the resignations flow......
real answers
Why do Sanofi and Libtayo management dislike each other? How do you expect the sales teams to produce results with our leaders acting like spoiled children in the sandbox fighting for the spotlight and credit?
Well let's see.....Insights into Oncology and management?
There’s a foul odor coming from the oncology BU- smells like death.
Libtato is a bust. How long before “field staffers” get the boot?
This drug is a dog. Most the clinical trials discontinued since we were hired. It’s not the big we signed up for. Basal/cervical/lung all scrapped or years behind. At least the pay is average and we barely work at HQ, management and sales. Someday soon the gravy train will end when Pembro gets approved and we are all laid off or shuffled to another drug.